Metraipolis › archive › dc_abf5bb17f13b
Serum MIC-1, LMTK-3 and IGFBP-7 levels in the prognosis of lung cancer treated with ablation combined with chemotherapy — Europe PMC PMID:42781307
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42781307
- DOI
- 10.5937/jomb0-62184
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-03T14:13:05.831Z
- SHA-256 of the archived text
9052ebd797d733c77e5a66c55163830840684a810953bc5bc4394f0255401ece- Stable URL of this page
https://metraipolis.com/documento/dc_abf5bb17f13b
How to cite
Serum MIC-1, LMTK-3 and IGFBP-7 levels in the prognosis of lung cancer treated with ablation combined with chemotherapy — Europe PMC PMID:42781307 — Europe PMC (en), https://europepmc.org/article/MED/42781307 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_abf5bb17f13b (Metraipolis archive dc_abf5bb17f13b, sha256 9052ebd797d733c77e5a66c55163830840684a810953bc5bc4394f0255401ece)
BibTeX
@misc{dcabf5bb17f13b,
title = {Serum MIC-1, LMTK-3 and IGFBP-7 levels in the prognosis of lung cancer treated with ablation combined with chemotherapy — Europe PMC PMID:42781307},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42781307},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_abf5bb17f13b; sha256 9052ebd797d733c77e5a66c55163830840684a810953bc5bc4394f0255401ece},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42781307. Agents can read the archived copy with the MCP tool read_document.